Spots Global Cancer Trial Database for caelyx
Every month we try and update this database with for caelyx cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Caelyx Biweekly in Heavily Pretreated Patients With Relapsed Ovarian Cancer | NCT00170573 | Ovarian Cancer | Caelyx | 18 Years - | North Eastern German Society of Gynaecological Oncology | |
| A Study Comparing the Combination of Trabectedin (YONDELIS) and DOXIL/CAELYX With DOXIL/CAELYX for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer | NCT01846611 | Ovarian Neoplas... Peritoneal Neop... Fallopian Tube ... | Trabectedin DOXIL Dexamethasone DOXIL | 18 Years - | Janssen Research & Development, LLC | |
| A Study to Compare CAELYX With Topotecan HCL in Patients With Recurrent Epithelial Ovarian Carcinoma Following Failure of First-Line, Platinum-Based Chemotherapy | NCT01840943 | Epithelial Ovar... | CAELYX Topotecan HCl | 18 Years - | Xian-Janssen Pharmaceutical Ltd. | |
| A Study to Compare CAELYX With Topotecan HCL in Patients With Recurrent Epithelial Ovarian Carcinoma Following Failure of First-Line, Platinum-Based Chemotherapy | NCT01840943 | Epithelial Ovar... | CAELYX Topotecan HCl | 18 Years - | Xian-Janssen Pharmaceutical Ltd. | |
| MK-4827 in Combination With Pegylated Liposomal Doxorubicin in Participants With Advanced Solid Tumors and Ovarian Cancer (MK-4827-011) | NCT01227941 | Ovarian Cancer | MK-4827 + pegyl... MK-4827 + pegyl... | 18 Years - | Tesaro, Inc. | |
| CAELYX Versus Paclitaxel HCl in Patients With Epithelial Ovarian Carcinoma Following Failure of First-Line, Platinum-Based Chemotherapy | NCT00653952 | Ovarian Neoplas... | CAELYX Paclitaxel HCl | 18 Years - | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | |
| Caelyx Adjuvant in Elderly Breast Cancer | NCT00284336 | Breast Cancer Elderly | Caelyx endoxan | 65 Years - | Universitaire Ziekenhuizen KU Leuven | |
| MK-4827 in Combination With Pegylated Liposomal Doxorubicin in Participants With Advanced Solid Tumors and Ovarian Cancer (MK-4827-011) | NCT01227941 | Ovarian Cancer | MK-4827 + pegyl... MK-4827 + pegyl... | 18 Years - | Tesaro, Inc. | |
| Single Dose of Intravenous rhTNF-α and Liposomal Doxorubicin in Patients With Advanced Solid Tumors or Lymphomas | NCT01490047 | Solid Tumors Lymphomas | Recombinant hum... Liposomal doxor... Caelyx Recombinant hum... | 18 Years - | Ludwig Institute for Cancer Research | |
| Lapatinib Plus Caelyx in Patients With Advanced Metastatic Breast Cancer Following Failure of Trastuzumab Therapy | NCT00903656 | Metastatic Brea... | doxorubicinhydr... | 18 Years - | Arbeitsgemeinschaft medikamentoese Tumortherapie | |
| An Efficacy and Safety Study for Yondelis (Trabectedin) in Patients With Advanced Relapsed Ovarian Cancer | NCT00113607 | Ovarian Cancer | Trabectedin DOXIL Dexamethasone | 18 Years - | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | |
| TLD-1, a Novel Liposomal Doxorubicin, in Patients With Advanced Solid Tumors | NCT03387917 | Advanced Solid ... | TLD-1 Caelyx | 18 Years - | Swiss Group for Clinical Cancer Research | |
| Caelyx Adjuvant in Elderly Breast Cancer | NCT00284336 | Breast Cancer Elderly | Caelyx endoxan | 65 Years - | Universitaire Ziekenhuizen KU Leuven | |
| A Study Comparing the Combination of Trabectedin (YONDELIS) and DOXIL/CAELYX With DOXIL/CAELYX for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer | NCT01846611 | Ovarian Neoplas... Peritoneal Neop... Fallopian Tube ... | Trabectedin DOXIL Dexamethasone DOXIL | 18 Years - | Janssen Research & Development, LLC |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
